The risk of uveitis in patients with JIA receiving etanercept: the challenges of analysing real-world data

Outcomes of non-infectious Paediatric uveitis in the era of biologic therapy

(2018) Megan Cann et al.   Pediatric Rheumatology

Adalimumab for Uveitis in Juvenile Idiopathic Arthritis

(2017)   NEW ENGLAND JOURNAL OF MEDICINE

Incidence and predictors of Uveitis in juvenile idiopathic arthritis in a Nordic long-term cohort study

(2017) Ellen Nordal et al.   Pediatric Rheumatology

Factors associated with choice of biologic among children with Juvenile Idiopathic Arthritis: results from two UK paediatric biologic registers

(2016) Lianne Kearsley-Fleet et al.   RHEUMATOLOGY

Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA)

(2015) Jens Klotsche et al.   ANNALS OF THE RHEUMATIC DISEASES

Uveitis associated with juvenile idiopathic arthritis

(2015) Ethan S. Sen et al.   Nature Reviews Rheumatology

Juvenile Idiopathic Arthritis

(2012) Peter J. Gowdie et al.   PEDIATRIC CLINICS OF NORTH AMERICA

Multiple imputation using chained equations: Issues and guidance for practice

(2010) Ian R. White et al.   STATISTICS IN MEDICINE

Development and validation of a composite disease activity score for juvenile idiopathic arthritis

(2009) Alessandro Consolaro et al.   ARTHRITIS AND RHEUMATISM